Holen Sie sich die Stockscreener-App
80.34
0.86%
0.6831
Schlusskurs vom Vortag:
$79.66
Offen:
$79.7
24-Stunden-Volumen:
3,311
Relative Volume:
0.64
Marktkapitalisierung:
$281.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.16%
1M Leistung:
+5.72%
6M Leistung:
+23.43%
1J Leistung:
+14.56%
1-Tages-Spanne:
$79.54
$80.34
1-Wochen-Bereich:
$79.54
$82.24
52-Wochen-Spanne:
$54.52
$83.59
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Firmenname
Invesco Biotechnology Genome Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PBE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
80.34 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
338.73 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
687.57 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
690.92 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
263.38 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
627.61 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Aktie (PBE) Neueste Nachrichten
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - sharewise.com
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - MSN
Inside the Recent Strength in Biotech ETFs - TradingView
Genome ETF stock announce special dividendWeekly Trade Summary & Stepwise Entry and Exit Trade Signals - newser.com
Genome ETF stock considered safe havenJuly 2025 Setups & Stepwise Trade Signal Implementation - newser.com
2 ETFs to Watch for Outsized Volume on Biotechnology Stocks - TradingView
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.2341 - MSN
Genome ETF stock compared to rivalsJuly 2025 News Drivers & Precise Swing Trade Alerts - Trung tâm Dự báo KTTV quốc gia
Genome ETF stockChart Signals & Fast Exit and Entry Trade Guides - newser.com
Wealth Enhancement Advisory Services LLC Sells 2,491 Shares of Invesco Biotechnology & Genome ETF $PBE - Defense World
Genome ETF stock benefit from mergersTrade Risk Summary & Consistent Return Strategy Ideas - newser.com
The Best Biotech ETFs to Buy - Kiplinger
Genome ETF stock deliver strong annual returnsJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - Benzinga
Signet Financial Management LLC Grows Position in Invesco Biotechnology & Genome ETF $PBE - Defense World
Invesco Biotechnology & Genome ETF $PBE Position Decreased by HighTower Advisors LLC - Defense World
7 Best Biotech ETFs to Buy Now - US News Money
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Sold by LPL Financial LLC - Defense World
Cetera Investment Advisers Has $1.34 Million Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Invesco (IVZ) Rallies 0.18% to Highest Since July 2025 Amid Asset Management Sector Reassessment - AInvest
PBE ETF: A Comprehensive Guide to Its Fundamentals and Performance - AInvest
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)? - Yahoo Finance
Invesco Nasdaq Biotechnology ETF IBBQ 2025Q2 Earnings Preview Upside Potential on Biotech Sector Growth - AInvest
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Purchased by Wealth Enhancement Advisory Services LLC - Defense World
Janney Montgomery Scott LLC Has $344,000 Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Full Year Ended April 30, 2025 - MarketScreener
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Short Interest Update - Defense World
Farther Finance Advisors LLC Acquires 6,201 Shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Wealth Enhancement Advisory Services LLC Raises Stake in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Two Sigma Investments LP Cuts Position in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Finanzdaten der Invesco Biotechnology Genome Etf-Aktie (PBE)
Es liegen keine Finanzdaten für Invesco Biotechnology Genome Etf (PBE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):